WEST PHARMACEUTICAL SERVICES INC Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
West Pharmaceutical Services Inc quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • West Pharmaceutical Services Inc Debt-to-equity for the quarter ending September 30, 2024 was 34 %, a 2.16% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 34 +0.72 +2.16% Sep 30, 2024
Q2 2024 33.3 -0.83 -2.43% Jun 30, 2024
Q1 2024 32.9 -2.44 -6.9% Mar 31, 2024
Q4 2023 32.9 -4.31 -11.6% Dec 31, 2023
Q3 2023 33.3 -5.73 -14.7% Sep 30, 2023
Q2 2023 34.2 -7.01 -17% Jun 30, 2023
Q1 2023 35.4 -7.21 -16.9% Mar 31, 2023
Q4 2022 37.2 -7.23 -16.3% Dec 31, 2022
Q3 2022 39 -7.58 -16.3% Sep 30, 2022
Q2 2022 41.2 -7.44 -15.3% Jun 30, 2022
Q1 2022 42.6 -7.36 -14.7% Mar 31, 2022
Q4 2021 44.4 -5.75 -11.5% Dec 31, 2021
Q3 2021 46.6 -3.07 -6.18% Sep 30, 2021
Q2 2021 48.6 -0.05 -0.1% Jun 30, 2021
Q1 2021 49.9 +1.76 +3.65% Mar 31, 2021
Q4 2020 50.2 +2.51 +5.27% Dec 31, 2020
Q3 2020 49.7 +3.82 +8.33% Sep 30, 2020
Q2 2020 48.7 Jun 30, 2020
Q1 2020 48.2 Mar 31, 2020
Q4 2019 47.7 Dec 31, 2019
Q3 2019 45.9 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.